• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Urine levels of type 1 collagen cross-linked N-telopeptides and deoxypyridinoline correlate with disease activity in rheumatoid arthritis.

作者信息

al-Awadhi A M, Olusi S O, al-Zaid N S, Prabha K, al-Jarallah K H, Ahmed A H, al-Salem I, Sedeqi H, Atteyah Y

机构信息

Department of Medicine, Faculty of Medicine, Kuwait University, Al-Safat, Kuwait.

出版信息

Clin Exp Rheumatol. 1998 Sep-Oct;16(5):569-72.

PMID:9779304
Abstract

OBJECTIVES

The aim of this study was to find out whether spot urinary concentrations of type 1 collagen cross-linked N-telopeptides (NTx) and deoxypyridinoline (Pyrilinks-D) can differentiate between active and inactive disease in rheumatoid arthritis (RA) and to investigate the extent to which they correlate with indices of disease activity.

METHODS

Using enzyme-linked immunosorbent assays, the concentrations of NTx and Pyrilinks-D were estimated in spot urine samples from 25 females with active disease, 25 females with inactive disease, and in 25 controls.

RESULTS

In Patients with active disease, urinary concentrations of NTx and Pyrilinks-D were significantly higher (p < 0.01) than in those with inactive disease or in healthy controls. In active disease there were significant positive correlation between urinary NTx and ESR, the swollen joint count, the tender joint count, and the patient's global assessment.

摘要

相似文献

1
Urine levels of type 1 collagen cross-linked N-telopeptides and deoxypyridinoline correlate with disease activity in rheumatoid arthritis.
Clin Exp Rheumatol. 1998 Sep-Oct;16(5):569-72.
2
Spot urine concentrations of type I collagen cross-linked N-telopeptides and deoxypyridinoline in psoriatic arthritis.
Clin Rheumatol. 1999;18(6):450-4. doi: 10.1007/s100670050137.
3
Urinary cross-linked N-telopeptides of type I collagen levels in patients with rheumatoid arthritis.类风湿关节炎患者尿中 I 型胶原交联 N-末端肽水平
Calcif Tissue Int. 2003 Apr;72(4):491-7. doi: 10.1007/s00223-002-1024-7. Epub 2003 Feb 10.
4
Serum B2-microglobulin concentration correlates with urinary concentrations of type 1 collagen cross-linked N-telopeptides and deoxypyridinoline in rheumatoid arthritis.
Ann Saudi Med. 1998 Mar-Apr;18(2):113-6. doi: 10.5144/0256-4947.1998.113.
5
Serum concentrations of interleukin 6, osteocalcin, intact parathyroid hormone, and markers of bone resorption in patients with rheumatoid arthritis.类风湿关节炎患者血清白细胞介素6、骨钙素、全段甲状旁腺激素及骨吸收标志物的浓度
J Rheumatol. 1999 Jun;26(6):1250-6.
6
Urinary type II collagen helical peptide (HELIX-II) as a new biochemical marker of cartilage degradation in patients with osteoarthritis and rheumatoid arthritis.尿II型胶原螺旋肽(HELIX-II)作为骨关节炎和类风湿关节炎患者软骨降解的新型生化标志物。
Arthritis Rheum. 2005 Apr;52(4):1081-90. doi: 10.1002/art.20930.
7
Serum osteocalcin levels in premenopausal rheumatoid arthritis patients.绝经前类风湿关节炎患者的血清骨钙素水平
Ann N Y Acad Sci. 2002 Jun;966:502-7. doi: 10.1111/j.1749-6632.2002.tb04254.x.
8
Arthritis instantaneously causes collagen type I and type II degradation in patients with early rheumatoid arthritis: a longitudinal analysis.关节炎在早期类风湿关节炎患者中会立即导致I型和II型胶原蛋白降解:一项纵向分析。
Ann Rheum Dis. 2006 Jan;65(1):40-4. doi: 10.1136/ard.2004.035196. Epub 2005 Aug 26.
9
Levels of markers of bone resorption are moderately increased in patients with inactive rheumatoid arthritis.
Rheumatology (Oxford). 2000 Jul;39(7):742-4. doi: 10.1093/rheumatology/39.7.742.
10
Telopeptides as markers of bone turnover in rheumatoid arthritis and osteoarthritis.端肽作为类风湿性关节炎和骨关节炎中骨转换的标志物。
Intern Med J. 2004 Sep-Oct;34(9-10):539-44. doi: 10.1111/j.1445-5994.2004.00647.x.

引用本文的文献

1
Relationship between bone mineral density and urine level of NTx in rheumatoid arthritis.
J Bone Miner Metab. 2005;23(4):314-7. doi: 10.1007/s00774-004-0605-0.